Paradigm Biopharmaceuticals Ltd.ASX: PAR

PAR reports pain reduction in 145 people with osteoarthritis

Nov 7, 2018 at 5:21 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment